Genpact Ltd. Hits New 52-Week Low at $27.40 Amid Declining Performance

Genpact has reached a new 52-week low, trading at USD 27.40 as of June 18, 2026. This marks a significant decline for the small-cap company, which has seen its stock price decrease by 14.08% over the past year, contrasting sharply with the S&P 500's performance of 25.41% during the same period. Despite the recent downturn, Genpact maintains a market capitalization of USD 6,250 million and exhibits strong management efficiency, highlighted by a return on equity of 22.53%. The company also boasts a low debt-to-equity ratio of 0.16, indicating a solid financial position. In terms of profitability, Genpact has shown resilience with an operating profit growth rate of 10.73% annually. The latest financial results reveal an operating cash flow of USD 649.51 million, alongside a dividend per share of USD 3.95, reflecting the company's commitment to returning value to shareholders. While the stock has faced challenges, its valuation metrics suggest it is trading at a discount compared to historical averages within its industry.